111 Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$307K Buy
+3,035
New +$314K 0.05% 349
2025
Q4
Sell
-5,195
Closed -$660K 394
2025
Q3
$660K Sell
5,195
-3,429
-40% -$408K 0.13% 172
2025
Q2
$1.06M Buy
8,624
+5,462
+173% +$624K 0.18% 125
2025
Q1
$320K Sell
3,162
-2,269
-42% -$222K 0.06% 308
2024
Q4
$502K Buy
+5,431
New +$533K 0.11% 210

Other funds holding EHC

111 Capital's EHC Position: Q2 2026 in Review

111 Capital opened a new position in Encompass Health (EHC) in Q2 2026: 3,035 shares worth $307K. The stake represents 0.05% of the portfolio and ranks #349 among its holdings. This is a return to the name: 111 Capital previously reported a position in EHC as recently as Q3 2025.

111 Capital first reported a position in EHC in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.06M in Q2 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • 111 Capital held 3,035 shares of Encompass Health worth $307K as of Q2 2026.
  • Encompass Health was a new 111 Capital position in Q2 2026.
  • Encompass Health made up 0.05% of 111 Capital's portfolio in Q2 2026, its #349 holding.
  • 111 Capital first reported a position in Encompass Health in Q4 2024 and has held it in 5 quarters since.
  • 111 Capital's Encompass Health position peaked at $1.06M in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.